Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

A Telemedicine System Intervention for Patients With Type 1 Diabetes: Pilot Feasibility Crossover Intervention Study

M. Vlasakova, J. Muzik, A. Holubová, D. Fiala, E. Arsand, J. Urbanová, D. Janíčková Žďárská, M. Brabec, J. Brož

. 2023 ; 7 (-) : e35064. [pub] 20230428

Status neindexováno Jazyk angličtina Země Kanada

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23009889

BACKGROUND: Today's diabetes-oriented telemedicine systems can gather and analyze many parameters like blood glucose levels, carbohydrate intake, insulin doses, and physical activity levels (steps). Information collected can be presented to patients in a variety of graphical outputs. Despite the availability of several technical means, a large percentage of patients do not reach the goals established in their diabetes treatment. OBJECTIVE: The objective of the study was to evaluate the benefits of the Diani telemedicine system for the treatment of patients with type 1 diabetes mellitus. METHODS: Data were collected during a 24-week feasibility study. Patients responded to the World Health Organization Quality of Life - BREF (WHOQOL-BREF) questionnaire and a system evaluation questionnaire. The level of glycated hemoglobin (HbA1c) and the patient's body weight were measured, and the patient's use of the telemedicine system and their daily physical activity level were monitored. All data were sent from the patient's device to the Diani server using a real-time diabetes diary app. Wilcoxon and Friedman tests and the linear mixed effects method were used for data analysis. RESULTS: This study involved 10 patients (men: n=5; women: n=5), with a mean age of 47.7 (SD 19.3) years, a mean duration of diabetes of 10.5 (SD 8.6) years, and a mean HbA1c value of 59.5 (SD 6.7) mmol/mol. The median number of days the patients used the system was 84. After the intervention, the mean HbA1c decreased by 4.35 mmol/mol (P=.01). The patients spent 18.6 (SD 6.8) minutes on average using the app daily. After the intervention, the number of patients who measured their blood glucose level at least 3 times a day increased by 30%. The graphical visualization of the monitored parameters, automatic transmission of measured data from the glucometer, compatibility, and interconnection of individual devices when entering data were positively evaluated by patients. CONCLUSIONS: The Diani system was found to be beneficial for patients with type 1 diabetes mellitus in terms of managing their disease. Patients perceived it positively; it strengthened their knowledge of diabetes and their understanding of the influences of the measured values on the management of their disease. Its use had a positive effect on the HbA1c level.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23009889
003      
CZ-PrNML
005      
20230721095416.0
007      
ta
008      
230707s2023 xxc f 000 0|eng||
009      
AR
024    7_
$a 10.2196/35064 $2 doi
035    __
$a (PubMed)37115601
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxc
100    1_
$a Vlasakova, Martina $u First Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/000000017445461X
245    12
$a A Telemedicine System Intervention for Patients With Type 1 Diabetes: Pilot Feasibility Crossover Intervention Study / $c M. Vlasakova, J. Muzik, A. Holubová, D. Fiala, E. Arsand, J. Urbanová, D. Janíčková Žďárská, M. Brabec, J. Brož
520    9_
$a BACKGROUND: Today's diabetes-oriented telemedicine systems can gather and analyze many parameters like blood glucose levels, carbohydrate intake, insulin doses, and physical activity levels (steps). Information collected can be presented to patients in a variety of graphical outputs. Despite the availability of several technical means, a large percentage of patients do not reach the goals established in their diabetes treatment. OBJECTIVE: The objective of the study was to evaluate the benefits of the Diani telemedicine system for the treatment of patients with type 1 diabetes mellitus. METHODS: Data were collected during a 24-week feasibility study. Patients responded to the World Health Organization Quality of Life - BREF (WHOQOL-BREF) questionnaire and a system evaluation questionnaire. The level of glycated hemoglobin (HbA1c) and the patient's body weight were measured, and the patient's use of the telemedicine system and their daily physical activity level were monitored. All data were sent from the patient's device to the Diani server using a real-time diabetes diary app. Wilcoxon and Friedman tests and the linear mixed effects method were used for data analysis. RESULTS: This study involved 10 patients (men: n=5; women: n=5), with a mean age of 47.7 (SD 19.3) years, a mean duration of diabetes of 10.5 (SD 8.6) years, and a mean HbA1c value of 59.5 (SD 6.7) mmol/mol. The median number of days the patients used the system was 84. After the intervention, the mean HbA1c decreased by 4.35 mmol/mol (P=.01). The patients spent 18.6 (SD 6.8) minutes on average using the app daily. After the intervention, the number of patients who measured their blood glucose level at least 3 times a day increased by 30%. The graphical visualization of the monitored parameters, automatic transmission of measured data from the glucometer, compatibility, and interconnection of individual devices when entering data were positively evaluated by patients. CONCLUSIONS: The Diani system was found to be beneficial for patients with type 1 diabetes mellitus in terms of managing their disease. Patients perceived it positively; it strengthened their knowledge of diabetes and their understanding of the influences of the measured values on the management of their disease. Its use had a positive effect on the HbA1c level.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Muzik, Jan $u First Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Information and Communication Technologies in Medicine, Faculty of Biomedical Engineering, Czech Technical University in Prague, Praha, Czech Republic $1 https://orcid.org/0000000248517899
700    1_
$a Holubová, Anna $u First Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Information and Communication Technologies in Medicine, Faculty of Biomedical Engineering, Czech Technical University in Prague, Praha, Czech Republic $1 https://orcid.org/0000000341096670
700    1_
$a Fiala, Dominik $u First Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Information and Communication Technologies in Medicine, Faculty of Biomedical Engineering, Czech Technical University in Prague, Praha, Czech Republic $1 https://orcid.org/000000016523683X
700    1_
$a Arsand, Eirik $u University of Tromsø - The Arctic University of Norway, Tromsø, Norway $u Norwegian Centre for E-health Research, Tromsø, Norway $1 https://orcid.org/0000000295201408
700    1_
$a Urbanová, Jana $u Department of Internal Medicine, Faculty Hospital Kralovske Vinohrady, Center for Research in Diabetes, Metabolism and Nutrition, Charles University Third Faculty of Medicine, Prague, Czech Republic $1 https://orcid.org/0000000288606124
700    1_
$a Janíčková Žďárská, Denisa $u Department of Internal Medicine, Second Medical Faculty, Charles University and Motol University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000281437276
700    1_
$a Brabec, Marek $u Institute of Computer Science, Academy of Science of the Czech Republic, Prague, Czech Republic $1 https://orcid.org/0000000163675791
700    1_
$a Brož, Jan $u Department of Internal Medicine, Second Medical Faculty, Charles University and Motol University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000324657333 $7 xx0046397
773    0_
$w MED00209098 $t JMIR formative research $x 2561-326X $g Roč. 7, č. - (2023), s. e35064
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37115601 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230707 $b ABA008
991    __
$a 20230721095410 $b ABA008
999    __
$a ok $b bmc $g 1958550 $s 1196153
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 7 $c - $d e35064 $e 20230428 $i 2561-326X $m JMIR formative research $n JMIR Form Res $x MED00209098
LZP    __
$a Pubmed-20230707

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...